Fibromyalgia does not cause neuropathy in the way diabetes or chemotherapy does, but the boundary between the two conditions is far blurrier than most people realize. Research over the past decade has found that roughly half of people diagnosed with fibromyalgia show objective evidence of damage to their smallest nerve fibers, a condition called small fiber neuropathy. Whether that nerve damage is a separate problem hiding under a fibromyalgia label or part of fibromyalgia itself remains one of the more contentious questions in pain medicine.
How Nerve Damage Was Found in Fibromyalgia Patients
For most of its history, fibromyalgia was considered a disorder of central pain processing, with no detectable damage to nerves or tissues. Standard nerve conduction studies in fibromyalgia patients came back normal because those tests measure large nerve fibers, and large fibers in fibromyalgia are generally fine. The turning point came when researchers started using skin punch biopsies, a technique where a tiny sample of skin is taken (usually from the lower leg) and examined under a microscope to count the density of the tiniest nerve endings threading up through the skin’s outer layer.
A 2013 study at Massachusetts General Hospital found that about 41% of fibromyalgia patients had skin biopsies diagnostic for small fiber polyneuropathy, compared to just 3% of healthy controls.1PubMed Central. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia That study was a landmark because it provided the first hard, measurable evidence that something was physically wrong with the nerves of a sizable chunk of fibromyalgia patients. Later work from multiple groups has broadly confirmed those numbers. A meta-analysis pooling results across studies estimated the overall prevalence of small fiber pathology in fibromyalgia at about 49%, with skin biopsy studies specifically finding it in around 45% and corneal confocal microscopy detecting it in roughly 59%.2PubMed. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis
Which Nerve Fibers Are Involved
The nerve damage seen in fibromyalgia is selective. It affects unmyelinated C-fibers and thinly myelinated Aδ fibers, the ones responsible for transmitting pain, temperature, and itch sensations as well as controlling things like sweating and blood flow. The thicker, faster myelinated fibers that handle muscle control and vibration sense are consistently spared. Skin biopsy studies have confirmed reduced numbers of dermal unmyelinated fibers alongside normal counts of dermal myelinated fibers, pointing to a process that targets the smallest caliber nerves specifically.3PubMed Central. Small fiber pathology in fibromyalgia syndrome – Section: 2. Small fiber pathology in fibromyalgia: data from skin biopsy studies A separate study using multiple testing methods, including quantitative sensory testing and pain-related evoked potentials alongside skin biopsies, found that all three approaches pointed toward impaired small fiber function while large fibers remained intact.4Brain. Small fibre pathology in patients with fibromyalgia syndrome
This selectivity matters because it explains a common clinical frustration. A person with fibromyalgia goes to a neurologist, gets a standard nerve conduction study, and the results come back normal. That is expected, because conventional electrodiagnostics only assess the large fibers. The small fibers require specialized tests to evaluate, and many clinicians still do not order them routinely.
Why Fibromyalgia and Neuropathy Symptoms Overlap So Much
One reason people search for a connection between fibromyalgia and neuropathy is that the symptoms can feel identical. Burning pain, prickling, numbness, tingling, and touch-evoked pain (allodynia) are hallmarks of neuropathic conditions, and they show up frequently in fibromyalgia too. A large comparison study of over 3,000 patients with either fibromyalgia or diabetic painful neuropathy found that patients from both groups chose very similar words to describe their sensory experiences. Burning pain, prickling, and allodynia were present at similar rates in both conditions, and two of the five sensory profiles identified by the researchers occurred frequently in patients from either group.5BMC Neurology. Fibromyalgia and neuropathic pain – differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia
Scores on standardized neuropathic pain questionnaires are also elevated in fibromyalgia. One study found that symptoms like paresthesia, hyperalgesia, and allodynia were significantly more common in fibromyalgia patients than in controls, and scores on both the painDETECT and LANSS neuropathic pain scales were meaningfully higher.6PubMed Central. Is Fibromyalgia Syndrome a Neuropathic Pain Syndrome? Dry eyes, dry mouth, and abnormal sweating, all symptoms tied to autonomic small fiber dysfunction, are also common. A national survey of fibromyalgia patients found that around 46% had three or more symptoms suggestive of small fiber pathology.7PubMed. Neuropathic pain and symptoms of potential small-fiber neuropathy in fibromyalgic patients: A national on-line survey
The Pain Classification Problem
Pain researchers now recognize three broad categories of pain. Nociceptive pain comes from actual tissue damage, like a broken bone or a cut. Neuropathic pain comes from injury or disease affecting the nerves themselves. And nociplastic pain, a newer term, describes pain arising from altered processing in the nervous system without clear evidence of tissue damage or nerve injury.8Annals of the Rheumatic Diseases. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here? Fibromyalgia has been the prototypical nociplastic pain condition, with the assumption being that the nervous system’s volume knob is turned up too high rather than any peripheral nerve being damaged.
The discovery of small fiber pathology in so many fibromyalgia patients complicates that tidy classification. If half of people with fibromyalgia have measurable nerve damage, their pain could qualify as at least partly neuropathic. Some researchers have proposed that mild damage to peripheral nerve fibers may act as a trigger for an exaggerated central pain response in people who are already predisposed to heightened pain processing.9PubMed. The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: a narrative review on neurophysiological and morphological evidence Under this model, fibromyalgia is neither purely central nor purely peripheral but a feedback loop between the two. One study using electrochemical skin conductance testing found that central sensitization and small fiber abnormalities co-existed in the same patients, with extreme central sensitization scores predicting a higher likelihood of small fiber dysfunction.10The Clinical Journal of Pain. Central Sensitization and Small-fiber Neuropathy Are Associated in Patients With Fibromyalgia
An Autoimmune Explanation Is Gaining Ground
One of the most provocative findings in recent fibromyalgia research comes from passive transfer experiments. Researchers took IgG antibodies from fibromyalgia patients and injected them into mice. The mice developed increased sensitivity to painful pressure and cold, reduced grip strength, decreased physical activity, and a measurable loss of nerve endings in the skin, mimicking several core features of fibromyalgia. Mice that received IgG from healthy controls or antibody-depleted serum from fibromyalgia patients showed none of these changes.11PubMed Central. Passive transfer of fibromyalgia symptoms from patients to mice
Follow-up work using electrophysiology recordings from nerve fibers in those mice showed that C-fiber and Aδ-fiber afferents innervating the skin fired significantly more in animals treated with fibromyalgia IgG, specifically producing sustained activity after mechanical stimulation rather than during it. The researchers noted that this pattern mirrors the nociceptor hyperexcitability observed in people with fibromyalgia.12The Journal of Physiology. Mechanical sensitization of sensory afferents after passive transfer of fibromyalgia IgG If confirmed in larger human studies, this would mean that at least some fibromyalgia is driven by autoantibodies attacking or sensitizing peripheral nerves, which would make the nerve damage a direct consequence of an immune process rather than a coincidental finding.
Separate from the antibody work, there is broader evidence of neurogenic inflammation in fibromyalgia involving neuropeptides, chemokines, and cytokines that activate both innate and adaptive immune responses. This inflammatory process has been linked to peripheral symptoms like swelling and abnormal skin sensations as well as central symptoms like fatigue and cognitive difficulties.13PubMed. Neurogenic inflammation in fibromyalgia
Autonomic Symptoms and How They Fit In
Small fibers do not just carry pain signals. They also run the autonomic nervous system, controlling heart rate adjustments, blood pressure regulation, sweating, digestion, and pupil dilation. Many people with fibromyalgia experience autonomic symptoms like lightheadedness on standing, rapid heart rate, abnormal sweating, and digestive problems. The question is whether those symptoms reflect actual autonomic nerve damage or just the brain amplifying normal sensations.
The answer appears to be somewhere in between. One study comparing fibromyalgia patients to controls found dramatic differences in self-reported autonomic symptoms but only mild objective abnormalities on formal autonomic reflex testing, limited to the adrenergic domain. About 45% of patients showed no measurable autonomic dysfunction at all, and only 10% had moderate abnormalities.14PubMed Central. Patients with Fibromyalgia Have Significant Autonomic Symptoms but Modest Autonomic Dysfunction However, more recent work that stratified patients by whether they had confirmed small fiber pathology on skin biopsy told a different story. Across the whole fibromyalgia group, heart rate variability was reduced and sympathetic nervous system activity was elevated compared to controls, but patients who also had confirmed small fiber pathology showed greater impairment, with more pronounced rapid heart rate responses and worse orthostatic symptoms during tilt testing.15PubMed. Autonomic dysfunction in fibromyalgia syndrome: the role of small fiber damage The subgroup with documented nerve damage, in other words, had autonomic dysfunction that was objectively worse.
Does the Nerve Damage Actually Change the Pain?
This is the question the field has wrestled with most. Finding nerve damage in fibromyalgia patients does not automatically mean that damage is causing their symptoms. It could be a bystander effect, a consequence of the same upstream process without being the main driver of pain. One study tested this directly by looking at whether fibromyalgia patients with reduced nerve fiber density on biopsy responded better to medications designed for neuropathic pain. If nerve damage were driving their pain, you would expect those patients to get more relief from neuropathic-targeted drugs. The hypothesis was not confirmed.16Pain Research and Management. Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study
Another study went further, comparing sensory function in fibromyalgia patients with and without small fiber pathology. Despite the difference in nerve fiber density, the sensory profiles of the two subgroups were remarkably similar, suggesting that small fiber pathology had a negligible impact on how the somatosensory system actually functioned. That same study also screened for genetic variants in voltage-gated sodium channels, which are a known cause of inherited small fiber neuropathy, and found relevant mutations in only a handful of patients. The researchers suggested that some patients with true small fiber neuropathy caused by these channel mutations may be getting misdiagnosed with fibromyalgia.17Pain. Small-fibre pathology has no impact on somatosensory system function in patients with fibromyalgia
Yet brain imaging studies complicate the picture again. When fibromyalgia patients were divided into subgroups based on skin biopsy results, those with reduced nerve fiber density showed distinct patterns of hyperconnectivity between brain regions involved in pain processing and attention, including the inferior frontal gyrus, angular gyrus, and posterior parietal cortex.18PubMed Central. Small Fibre Pathology in Fibromyalgia: A review – Section: CNS Alterations and Pain Mechanisms The subgroup with peripheral nerve involvement also had measurable differences in cortical volume and white matter integrity in the brain.19Scientific Reports. CNS imaging characteristics in fibromyalgia patients with and without peripheral nerve involvement Whatever the nerve damage means functionally, it does correlate with distinct changes in the brain, suggesting the peripheral and central components are connected rather than independent.
Separating Fibromyalgia from True Small Fiber Neuropathy
The clinical overlap between fibromyalgia and small fiber neuropathy is large enough that some researchers have asked whether the two conditions are really the same thing. They are not, at least not entirely. A clinical guide aimed at helping physicians distinguish between the two highlighted several differences. Patients with isolated small fiber neuropathy were more likely to have impaired glucose metabolism (prediabetes or diabetes), which is one of the most common treatable causes of small fiber damage. Searching for glucose metabolism problems is considered especially important in patients who carry both diagnoses, because correcting blood sugar can sometimes improve nerve fiber density over time.20PubMed Central. Distinguishing fibromyalgia syndrome from small fiber neuropathy: a clinical guide – Section: 4. Discussion
The distribution of symptoms also tends to differ. Classic small fiber neuropathy usually starts in the feet and creeps upward in a length-dependent pattern, following the longest nerves first. Fibromyalgia pain is typically widespread from the start, affecting the trunk, shoulders, and limbs simultaneously rather than marching upward from the toes. Fatigue, unrefreshing sleep, and cognitive fog, while they can occur in small fiber neuropathy, are much more prominent in fibromyalgia and often dominate the clinical picture. A person whose main complaints are burning feet and nothing else probably has a neuropathy. A person with full-body pain, crushing fatigue, and sleep disruption who also happens to have burning feet is more likely to have fibromyalgia with possible small fiber involvement.
What This Means for Treatment
If you have fibromyalgia and suspect you might also have small fiber neuropathy, the practical question is whether identifying it changes what your doctors can do for you. The honest answer is: sometimes. Standard fibromyalgia treatments like duloxetine, pregabalin, exercise programs, and cognitive behavioral approaches remain the backbone of management regardless of biopsy results. As noted above, patients with confirmed nerve fiber loss did not respond meaningfully better to neuropathic pain medications in at least one study.
The more exciting treatment angle involves targeting the immune system. Small pilot studies have reported that intravenous immunoglobulin (IVIg) improved both fibromyalgia symptoms and skin biopsy findings in patients who had fibromyalgia with confirmed small fiber neuropathy, with patients reporting fewer symptoms and biopsies showing improved nerve fiber density after six months of treatment.21PubMed. Improvement of Nerve Fiber Density in Fibromyalgia Patients Treated with IVIg Those are promising results, but they come from small retrospective studies without placebo controls, so they need to be interpreted cautiously. IVIg is also extremely expensive and not easy to access. Larger, controlled trials are needed before immunotherapy becomes a standard option for fibromyalgia patients with small fiber involvement.
The most actionable step right now is probably diagnostic rather than therapeutic. If you have fibromyalgia, getting screened for treatable causes of small fiber neuropathy, particularly glucose metabolism problems, vitamin deficiencies, and autoimmune conditions, could uncover something fixable. A skin punch biopsy is a simple outpatient procedure, and if it reveals reduced nerve fiber density, that opens the door to investigating why and potentially addressing the underlying cause.
Nerve Fiber Loss in Children and Adolescents with Fibromyalgia
Most fibromyalgia research focuses on adults, but the small fiber findings extend to younger patients too. A study of adolescents with juvenile fibromyalgia found that about 53% had nerve fiber density below the fifth percentile for their age, compared to 4% of healthy controls, with mean nerve fiber density significantly lower in the patient group.22The Journal of Rheumatology. Epidermal Neurite Density in Skin Biopsies From Patients With Juvenile Fibromyalgia A separate study of children and adolescents with unexplained widespread pain syndromes used multiple testing methods and diagnosed definite small fiber polyneuropathy in 59% and probable small fiber polyneuropathy in an additional 17%. Only one patient out of 41 had entirely normal results across all tests.23Pediatrics. Evidence of Small-Fiber Polyneuropathy in Unexplained, Juvenile-Onset, Widespread Pain Syndromes
These pediatric findings are striking because they suggest that the nerve fiber loss is not simply a result of decades of chronic pain wearing nerves down. It appears early, sometimes in childhood, which raises the possibility that the nerve damage is either a very early event in the disease process or is driven by something systemic that starts well before adulthood. The fact that prevalence rates in children are similar to those in adults also argues against the idea that the nerve loss is just an incidental finding that accumulates with age.
Corneal Confocal Microscopy as a Non-Invasive Alternative
Skin biopsy, while straightforward, is still a minor surgical procedure. An alternative approach involves corneal confocal microscopy, a painless imaging technique that photographs the tiny nerve fibers in the surface of the eye. The cornea is one of the most densely innervated tissues in the body, and its nerve fibers are small enough to reflect the same pathology seen in skin biopsies. One study comparing women with fibromyalgia to healthy controls found that fibromyalgia patients had thinner corneal stromal nerves and lower nerve fiber density in the sub-basal nerve plexus. Thinner corneal nerves were also associated with higher scores on neuropathic pain questionnaires.24PubMed. Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy The meta-analysis mentioned earlier found that corneal microscopy detected small fiber pathology in around 59% of fibromyalgia patients, a somewhat higher rate than skin biopsy, possibly because the technique captures early or subtle changes that haven’t yet progressed to the point of reducing fiber counts in the skin.25PubMed. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis If this approach becomes more widely available, it could make screening for small fiber involvement much easier and less invasive.